Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Skin structural proteins constitute a diverse group of molecules, including keratins, collagens, and elastin, which are fundamental to the mechanical integrity and physiological function of the skin (StatPearls, 2023). Keratins form the primary cytoskeletal framework of the epidermis, while filaggrin is essential for aggregating these filaments to maintain the stratum corneum barrier (PubMed, PMID: 29411831). In the dermis, Type I and Type III collagens provide tensile strength, and elastin fibers allow the skin to return to its original shape after stretching (NIH, 2022). These proteins are critical in the pathology of various conditions; for instance, collagen degradation is a hallmark of skin aging, and mutations in filaggrin are strongly linked to atopic dermatitis (PubMed, PMID: 16550169). Pharmacological interventions often target these proteins indirectly; retinoids like tretinoin are well-documented to stimulate collagen synthesis and improve skin texture (PubMed, PMID: 17515510). Additionally, topical emollients and humectants are used to support the structural barrier formed by these proteins in xerotic and inflammatory skin diseases. Because this category encompasses multiple distinct protein families, it is considered a non-specific therapeutic target grouping rather than a single molecular entity.
Stimulation of protein synthesis (e.g., collagen via retinoids), protection against proteolytic degradation, and physical reinforcement of the skin barrier.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Skin structural proteins.